Business Segments Thiogenesis Therapeutics, Corp. OTC Markets
Stocks
TTIPF
CA88410L1022
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
09:54:44 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.3671 USD | -12.57% |
|
-12.57% | -37.08% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2020 | 2021 | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|---|
Biological Products | ||||||
Net Income | -967K | -3.92M | -5.06M | -3.15M | -7.43M | |
Interest Expense | -2.43K | -4.12K | - | - | - | |
EBT | -967K | -3.92M | -5.06M | -3.15M | -7.43M | |
Total Assets | 182K | 6.29M | 7.24M | 3.98M | 1.81M |
| Fiscal Period: December | 2020 | 2021 | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|---|
EBT | -967K | -3.92M | -5.06M | -3.15M | -7.43M | |
Interest Expense | -2.43K | -4.12K | - | - | - | |
Net Income | -967K | -3.92M | -5.06M | -3.15M | -7.43M | |
Total Assets | 182K | 6.29M | 7.24M | 3.98M | 1.81M |
Select your edition
All financial news and data tailored to specific country editions
